Alan Main
Nessuna posizione attualmente
Patrimonio netto: 613 738 $ in data 31/03/2024
Profilo
Alan J.
Main served as the President & Chief Executive Officer at Coelacanth Corp.
from 2000 to 2001.
He then worked as the Senior Vice President-US Research at Novartis Pharmaceuticals Corp.
Following that, he held the position of Executive Vice President-Pharmaceutical Research at Lexicon Pharmaceuticals, Inc. from 2007 to 2015.
Dr. Main completed his undergraduate degree at the University of Aberdeen and obtained a doctorate from The University of Liverpool.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
18/03/2024 | 255 724 ( 0.10% ) | 613 738 $ | 31/03/2024 |
Precedenti posizioni note di Alan Main
Società | Posizione | Fine |
---|---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Chief Executive Officer | 01/07/2001 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
LEXICON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 11/03/2015 |
Formazione di Alan Main
University of Aberdeen | Undergraduate Degree |
The University of Liverpool | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Coelacanth Corp.
Coelacanth Corp. Miscellaneous Commercial ServicesCommercial Services Coelacanth Corp. is a company that researches drug development. The company is based in East Windsor, NJ. The company was founded by Robert Grubbs. Coelacanth was acquired by Lexicon Pharmaceuticals, Inc. on 2001-07-12 for $31.9 million. | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Borsa valori
- Insiders
- Alan Main